Structure-based assessment of BRCA1 and BRCA2 mutations in a small Spanish population
Salgado J, Zabalegui N, García-Amigot F, Gil MC, González MS, García-Foncillas J.
Laboratory of Biotechnology, University Clinic of Navarra, Avda. Pio XII 36, 31008 Pamplona, Navarra, Spain
Revista: Oncology Reports
Fecha: 01-jul-2005Área del Cáncer de Mama Unidad de Genética Clínica
Breast cancer is the most frequent cancer type among women in the world. There is abundant evidence, that alterations in the breast cancer susceptibility genes, BRCA1 and BRCA2, are present in a large proportion of families with multiple cases of breast and ovarian cancer.
Our aim was to better understand the molecular and structural insights associated with the most frequent alterations, found in the BRCA1 and BRCA2 genes, within our patients. We analyzed 50 breast cancer cases. Of those, 24% were found to carry deleterious mutations, and up to 10 rare variants of unknown significance were detected. The frequency of polymorphic changes was considerably different between genes, BRCA1 (55%) and BRCA2 (19.4%).
By looking at the protein level, the changes observed within the BRCA1 and BRCA2 genes could affect not only the nucleic location of the protein but also disrupt the folding and, therefore, the tumor suppressor function.
CITA DEL ARTÍCULO Oncol Rep. 2005 Jul;14(1):85-8
tal vezLE INTERESE
La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.
Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.
Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.